In BRAF V600E CRC cells lines Colo205 and HT‐29, inhibitors affecting the MAPK pathway at or below BRAF resulted in over twofold dose‐dependent increase in SPINK1 secretion measured at 72‐h time point (Fig. 3A,B). This evidence concerns the gene BRAF and colorectal carcinoma.